GNH USA

Europe — EMA

Levodopa/Carbidopa/Entacapone Stada Arzneimittel Ag

GNH USA supplies Levodopa/Carbidopa/Entacapone (Levodopa/Carbidopa/Entacapone), a dopamine precursor therapy for Parkinson's disease.

Carbidopa, Entacapone, Levodopa

Request sourcing

1
Pack/s

What is Carbidopa, Entacapone, Levodopa?

Levodopa, carbidopa, entacapone, the active ingredients in Levodopa/Carbidopa/Entacapone Stada Arzneimittel Ag, constitute a combination dopamine precursor therapy presented as an oral tablet for oral administration. The formulation is indicated for the management of Parkinson's disease and associated motor fluctuations in adult patients.

GNH USA supplies Levodopa/Carbidopa/Entacapone Stada Arzneimittel Ag as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality standards. The company adheres to EU GMP guidelines and offers logistical support for customs clearance and temperature‑controlled shipping where required.

What is Carbidopa, Entacapone, Levodopa used for?

Levodopa/Carbidopa/Entacapone is used in the dopaminergic pathway to manage Parkinsonian disorders.

- Parkinson's disease: improves overall motor function and reduces rigidity and bradykinesia. - Parkinson's disease motor fluctuations: decreases OFF periods and prolongs ON time without troublesome dyskinesia. - Parkinson's disease with wearing‑off phenomenon: stabilizes dopamine levels to smooth symptom control.

What are the side effects of Carbidopa, Entacapone, Levodopa?

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Nausea - Vomiting - Dizziness - Orthostatic hypotension - Insomnia - Dry mouth

Serious or Rare Side Effects: - Dyskinesia - Neuroleptic malignant syndrome - Severe hypotension - Hallucinations or psychosis - Anaphylactic or severe allergic reactions

What precautions apply to Carbidopa, Entacapone, Levodopa?

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should observe several safety measures.

- Blood pressure monitoring: check for orthostatic changes especially after dose initiation. - Psychiatric assessment: observe for hallucinations, confusion or mood changes. - Renal function evaluation: adjust dosing in severe impairment. - Hepatic function: monitor liver enzymes due to entacapone metabolism. - Hypersensitivity: discontinue if rash or angioedema occurs. - Store at room temperature: keep in original container, protect from moisture and light.

What does Carbidopa, Entacapone, Levodopa interact with?

Levodopa/Carbidopa/Entacapone interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine): risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol, risperidone): may diminish antiparkinson effect. - Other COMT inhibitors: additive toxicity.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: may increase risk of serotonin syndrome. - Antihypertensive agents: additive blood‑pressure lowering. - Iron or levodopa‑containing dietary supplements: reduce levodopa absorption. - Anticholinergic drugs: may enhance central side effects.

Frequently asked questions

What is Levodopa/Carbidopa/Entacapone used for?+
Levodopa/Carbidopa/Entacapone is prescribed to treat Parkinson's disease and to manage motor fluctuations such as OFF periods. It helps improve motor symptoms like rigidity, tremor, and bradykinesia by restoring dopamine levels in the brain.
How does Levodopa/Carbidopa/Entacapone work?+
The combination works on three levels: levodopa is converted to dopamine in the brain, carbidopa blocks peripheral conversion of levodopa to reduce side effects and increase central availability, and entacapone inhibits the COMT enzyme, prolonging levodopa’s plasma half‑life and enhancing its therapeutic effect.
What determines the dose of Levodopa/Carbidopa/Entacapone?+
Dosage is individualized and set by the prescribing clinician based on the patient’s disease severity, response to therapy, age, renal and hepatic function, and concomitant medications. No standard dose can be provided without a medical assessment.
Is Levodopa/Carbidopa/Entacapone safe in pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies the potential risk to the fetus or infant, and it is generally avoided unless absolutely necessary.
How do I order Levodopa/Carbidopa/Entacapone from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com where you specify the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.
How does this product compare with standard levodopa/carbidopa therapy?+
Standard levodopa/carbidopa provides dopamine replacement but has a shorter plasma half‑life, leading to more frequent dosing and motor fluctuations. Adding entacapone extends levodopa’s duration of action, reduces OFF time, and may allow fewer daily doses, offering smoother symptom control.
How should Levodopa/Carbidopa/Entacapone be stored and handled?+
Store the tablets at room temperature, preferably below 25 °C, in the original blister pack or container. Protect them from excessive moisture, heat and direct sunlight to maintain potency throughout the shelf life.
How is Levodopa/Carbidopa/Entacapone administered?+
The medication is taken orally, usually with food or a light snack to reduce gastrointestinal irritation. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.
What are the most serious risks to watch for while taking this medication?+
Serious adverse events include dyskinesia, neuroleptic malignant syndrome, severe hypotension, hallucinations or psychosis, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if any of these symptoms develop.
Who should not use Levodopa/Carbidopa/Entacapone?+
Individuals with known hypersensitivity to levodopa, carbidopa, entacapone or any excipients should avoid the product. It is also contraindicated in patients taking non‑selective MAO inhibitors and those with severe hepatic impairment without careful medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Carbidopa, Entacapone, Levodopa
Route
Oral Use
Manufacturer
Stada Arzneimittel Ag
Origin
EU

Related products